Litcius/Paper detail

Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19

Amjad Husain, Siddappa N. Byrareddy

2020Chemico-Biological Interactions86 citationsDOIOpen Access PDF

Topics & Concepts

Drug repositioningCytokine stormRepurposingDrugPI3K/AKT/mTOR pathwayDrug developmentCoronavirus disease 2019 (COVID-19)Drug discoveryPharmacologyViral replicationAntiviral drugMechanistic target of rapamycinApproved drugMedicineCoronavirusVirologyBiologyDiseaseBioinformaticsInfectious disease (medical specialty)VirusSignal transductionInternal medicineBiochemistryEcologyPI3K/AKT/mTOR signaling in cancerSirtuins and Resveratrol in MedicineCalcium signaling and nucleotide metabolism
Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19 | Litcius